Percentage of stage III colon cancer patients aged 18–80 years
who were prescribed chemotherapy
What will you need to report for each patient with
colon cancer for this measure?
If you select this measure for reporting, you will report:
n Whether or not you prescribed or documented chemotherapy
as received for Stage III colon cancer patients1
What if this process or outcome of care is not
appropriate for your patient?
There may be times when it is not appropriate that chemotherapy
is prescribed or documented as received for Stage III colon cancer
patients, due to:
n Documented reasons (eg, colon cancer patient is not eligible
In these cases, you will need to indicate that a documented reason
applies, specify the reason on the worksheet and in the medical
chart. The office/billing staff will then report the G-code that
represents these valid reasons (also called exclusions.)
This measure is to be reported for all patients aged 18–80 years with colon cancer —
once per reporting period.
Chemotherapy for Stage III Colon Cancer Patients
1Neoadjuvant and adjuvant chemotherapy should be reported. The reporting clinician is not required to have written the initial prescription; ‘prescribed’ can include managing
treatment started by another clinician.
PQRI 2007 Measure 72, Effective Date 07/01/2007
Adapted from ASCO/NCCN Quality Measures.
(Disclaimers, Copyright and other Notices indicated on the Coding Specifications document are incorporated by reference)